Wayne Daniel Klohs

This inventor holds 5 USPTO granted patents. Top assignees: Warner-Lambert Company, Hadasit Medical Research Services and Development Ltd.. Active years: 1992-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wayne Daniel Klohs. Retrieved from https://idiyas.com/inventor/wayne-daniel-klohs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 60.0

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 87(Granted Patents)

Location History:

Ann Arbor, MI (US) (1992 - 1998)
Ypsilanti, MI (US) (2002)

Company Filing History:

5 out of 2,538

Warner-Lambert Company

patents

1 out of 182

Hadasit Medical Research Services and Development Ltd.

patents

where one patent can have more than one assignee

Years Active: 1992-2002

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6469058 - Chemotherapy of cancer with actyldinaline in combination with gemcitabine capecitabine or cisplatin (2002-10-22),

2. 6344455 - N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, and irreversible inhibitor of tyrosine kinases (2002-02-05),

3. 5767110 - Combination chemotherapy (1998-06-16),

4. 5597830 - Combination chemotherapy (1997-01-28),

5. 5160727 - Tumor cell sensitization method using quinazolinedione derivatives (1992-11-03),

Title: Wayne Daniel Klohs: Innovator in Cancer Treatment

Introduction

Wayne Daniel Klohs is a notable inventor based in Ypsilanti, MI (US). He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of 5 patents, Klohs has focused on developing compounds that enhance the efficacy of chemotherapy.

Latest Patents

Klohs' latest patents include groundbreaking work in cancer treatment. One of his notable inventions is a method for chemotherapy of cancer using acetyldinaline in combination with gemcitabine, capecitabine, or cisplatin. This combination has shown synergistic effects in treating cancer. Another significant patent involves the compound N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, which acts as an irreversible inhibitor of tyrosine kinases. This invention also outlines methods for treating various conditions, including cancer, atherosclerosis, and psoriasis.

Career Highlights

Throughout his career, Klohs has worked with reputable organizations such as Warner-Lambert Company and Hadasit Medical Research Services and Development Ltd. His experience in these companies has contributed to his expertise in pharmaceutical research and development.

Collaborations

Klohs has collaborated with notable individuals in his field, including Charles Dale Kowal and Alexander James Bridges. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Wayne Daniel Klohs is a distinguished inventor whose work in cancer treatment has the potential to make a significant impact on medical science. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]